Immunotherapy, specifically the introduction of immune checkpoint inhibitors, has
transformed the treatment of cancer, enabling long-term tumour control even in individuals …

The introduction of immunotherapy into cancer treatment has radically changed clinical
management of tumors. However, only a minority of patients (approximately 10 to 30%) …

Objective: To evaluate the sites and frequencies of overall and initial lymph node (LN)
metastases (LNMs) of clinical T1N0 esophageal cancer. Background: The sites and …

Background Lymphopenia occurs commonly in esophageal squamous cell carcinoma
(ESCC) and may influence treatment outcomes. We aimed to examine its association with …

Purpose To evaluate the feasibility and efficacy of involved-field irradiation in definitive
chemoradiation therapy for locoregional esophageal squamous cell carcinoma. Methods …

Background Concurrent chemoradiotherapy (CCRT) is the standard treatment for locally
advanced esophageal squamous cell carcinoma (ESCC). However, the optimal …

Purpose Because of the scarcity of cervical esophageal cancer (CEC), data for this disease
entity is limited. We aim to evaluate the outcomes, prognostic factors and failure patterns of …

Objective The prognostic significance of CD147 expression in esophageal cancer patients
remains controversial. Using a meta-analysis, we investigated the prognostic and …

Background This randomised phase III study was conducted to investigate the efficacy of
extended nodal irradiation (ENI) and/or erlotinib in inoperable oesophageal squamous cell …

Objective To investigate the in vitro and in vivo anticancer effects of a chalcone against
KYSE-4 esophageal cancer cells. Methods A chalcone was synthesized via the molecular …